Betaine + glycerol + salcaprozate sodium
Betaine + glycerol + salcaprozate sodium has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Oct 31, 2026: “A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin Penetration”.
1 paper studies it4 findingsUpdated
1 new paper in 30 daysSee all 1 papers on betaine + glycerol + salcaprozate sodium
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Guangdong Provincial Department of Science and Technology and 2 more
- Animals1
What did studies of betaine + glycerol + salcaprozate sodium find?
4Studies of betaine + glycerol + salcaprozate sodium measured 4 outcomes, among them hyperglycemia, body-weight gain and semaglutide retention in skin.
Hyperglycemia
downin mice1
1 study
Hyperglycemia
downin mice1
Betaine + glycerol + salcaprozate sodium decreases hyperglycemia in mice (obese and diabetic mice).
“In obese and diabetic mice, BGS effectively suppressed body weight gain and ameliorated hyperglycemia.”
Animalsobese and diabetic mice
Pharmaceutics
Body-weight gain
downin mice1
1 study
Body-weight gain
downin mice1
Betaine + glycerol + salcaprozate sodium decreases body-weight gain in mice (obese and diabetic mice).
“In obese and diabetic mice, BGS effectively suppressed body weight gain and ameliorated hyperglycemia.”
Animalsobese and diabetic mice
Pharmaceutics
Semaglutide retention in skin
upin pigs1
1 study
Semaglutide retention in skin
upin pigs1
Betaine + glycerol + salcaprozate sodium increases semaglutide retention in skin in pigs (ex vivo; compared with phosphate-buffered saline) (86.34 ± 6.12 μg/cm2 at 24 h; approximately 4.51 times PBS).
“BGS enhanced semaglutide penetration and accumulation, with the amount retained in skin reaching 86.34 ± 6.12 μg/cm2 at 24 h, approximately 4.51 times that with PBS.”
Animalsex vivo; compared with phosphate-buffered salinedeep eutectic solventskin24 h
Pharmaceutics
Semaglutide aggregation
downin cells1
1 study
Semaglutide aggregation
downin cells1
Betaine + glycerol + salcaprozate sodium decreases semaglutide aggregation in cells (compared with phosphate-buffered saline; cell-free formulation assessment) (Peak particle size: 51.7 versus 125.9 nm in PBS).
“The BGS drug delivery system markedly suppressed semaglutide aggregation, shifting the peak particle size from 125.9 nm in phosphate-buffered saline (PBS) to 51.7 nm.”
Cellscompared with phosphate-buffered saline; cell-free formulation assessmentdeep eutectic solvent
Pharmaceutics